2021-2030 Analysis and Review Antifungal Agents Market
Antifungal Agents Market By Drug Type, By Therapeutic Indications, By Applications - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021 – 2030
The global antifungal agents market is expected to grow with a CAGR of 8.1% during the forecast period of 2022-2030. The antifungal agents are fungi static in nature used to prevent and treat mycoses such as candidiasis, ring worm etc. These are basically the drugs which help in detecting and eliminating fungal pathogens from foreign body with less toxic side effects to the body. A fungal infection generally happens in humans due to moist, unhygienic environment. The anti-fungal agent market is witnessing high growth in near future due to increasing awareness among people about myriad fungal infections etc. which helps in boosting this market.
NA Holds Largest revenues, APAC to Grow Fastest
The market is segmented on the basis of drug types, therapeutic actions and application. Echinocandins growing with a CAGR of 9.3% is expected to be the fastest growing segment in the drug types. The largest share of the market in terms of revenues is held by azoles drug segment. On the basis of geography, the market is majorly segmented into North America, Europe, APAC and ROW. North America market holds the largest market share and Asia Pacific market is expected to be the fastest growing region expected to attain a CAGR of 10.3% in the forecast period of 2022-2030.
Key Factors Impacting the Market Growth
Rising demand of Antifungal Agents in healthcare sector would be the key factor which drives the growth of global Antifungal Agents market. The major reason behind the growth of this market is increasing number of patients suffering from hygiene related diseases majorly in the developing countries. The Antifungal Agents market is forecasted to grow at higher rate in future due to rapid growth and rising concerns of peoples regarding health and infectious diseases all over the world. Rising popularity of over-the-counter drugs segment across the world that also helps in boosting the market.
Topical Drugs Continue to Dominate the Market
Topical drugs are expected to be the largest revenue generating segment, the topical drug market is expected to grow at a CAGR of 7.5%. Oral drugs are expected to be the second highest revenue generating segment growing with a CAGR of 8.7% during the forecasted period. The Aspergillosis segment is expected to be the third highest revenue generating segment growing with a CAGR of 8.4% during the forecast period of 2022-2030.
Acquisition to Lead the Market Players
Global market for antifungal agents has witnessed significant number of market entrants in the last decades, although, the new companies involved does not hold a large market share but they do serve their respective regions. Major companies involved in this market are; Astellas Pharma Inc., Johnson & Johnson, Teva pharma, Novartis and Pfizer. There are many key players in the global antifungal agent market. Companies are focusing on increasing their market share through various strategic initiatives. Among all the strategic initiatives acquisition is widely opted in the global antifungal market.
Historical & Forecast Period
This research report presents the analysis of each segment from 2020 to 2030 considering 2021 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment are calculated for the forecast period from 2022 to 2030.
Report Methodology
Market revenues and CAGR were derived from primary and secondary research. Both quantitative and qualitative trends were considered for extrapolation of market revenues. The derived market estimates were further validated from top down, bottom strategies and primary research. The scope of the market is limited to the following segments of product categories and region.
By Drug Type(2020-2030; US$ Mn)
By Therapeutic Indications
By Applications
By Region (2020-2030; US$ Mn)
Global Impact of Covid-19 Segment (2020-2021; US$ Mn)
Key questions answered in this report
$4,600 | |
$6,600 | |
$13,200 |
Request customization |
Get market alerts |
Ask for regional data |
Ask for country-specific data |